维普中文期刊产品整合服务
47篇 您的检索式:作者名="WALLEMACQ P"
    题名 作者 年代 出处 被引量
1Sirolimus and taemli- mus trough concentrations and dose requirements after kidney transplantation in relation to CYP3A5 and MDR1 polymorphisms and steroids 显示文摘Mourad M Mourad G Wallemacq P 2005Transplantation2005,80,7:1
2Formate kinetics in methanol poisoning显示文摘Hantson P Haufroid V Wallemacq P 0,,02:1
3CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guide- lines from an experimental study 显示文摘Haufroid V Wallemacq P VanKerckhove V 2006Am J Transplant2006,6,11:1
4FK506 (Tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical and analytical aspects显示文摘Wallemacq P E Reding R 1993Clin Chem1993,39,11:1
5Elect rophorese des proteins se- riques:comparaison of capillary zone electrophoresis capillary(Se bia) and agarose gel electrophorcsis Hydrasys(Sebia)显示文摘Lissoir B Wallemacq P Maisin D 2003Annales de Biologic Clinique2003,61,5:1
6Multisite analytical evaluation of the Abbott ARCHITECT cyclosporine assay显示文摘Wallemacq P Maine GT Berg K 0,,02:1
7Evaluation of peritoneal transport properties at onset of peritoneal dialysis and longitudinal follow-up显示文摘Clerbaux G Francart J Wallemacq P 2006Nephrol Dial Transplant2006,21,:1
8FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects显示文摘WALLEMACQ P E REDING R 1993ClinChem1993,39,11:1
9HPLC-high reso- lution mass spectrometry in clinical laboratory? 显示文摘Jiwan JL Wallemacq P H6rent MF 2011Clin Biochem2011,44,1:1
10Opportunities to optimize tacrolimus therapy in solid organ transplantation:report of the European Consensus Conference显示文摘Wallemacq P Armstrong P Brunet M 2009Ther Drug Monit2009,31,2:1
11CYP3A5 and ABCB1 polymorohisms and tacmlimus pharmacokinefics in Fenal transplant candidates:guiderlines from an experimental study显示文摘Haufroid V Wallemacq P VanKerckhovev 2006Am J Transplant2006,6,11:1
12Pharmaeokinetics of tacrolimus in paediatric liver transplant recipients显示文摘WALLEMACQ P E FURIAN V MOLLER A 1998Eur J Drug Metab Pharmacokinet1998,23,:1
13CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates:guidelines from an experimental study显示文摘HAUFROID V WALLEMACQ P VANKERCKHOVE V 2006Am J Transplant2006,6,11:1
14The influence of genetic polymorphisms of cytochrome P450 3A5 and ABCB1 on starting dose- and weight-standardized tacrolimus trough concentrations after kidney transplantation in relation to renal function显示文摘Mourad M Wallemacq P De Meyer M 2006Clin Chem Lab Med2006,44,10:1
15Evaluation of peritoneal transport properties at onset of peritoneal dialysis and longitudinal follow-up显示文摘Clerbaux G Francart J Wallemacq P 0,,:1
16CYP3A5 and ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guidelines from an experimental study显示文摘Haufroid V Wallemacq P Van Kerckhove V 2006Am J Transplant2006,6,11:1
17CYP3A5 said ABCB1 polymorphisms and tacrolimus pharmacokinetics in renal transplant candidates: guidelines from an experimental study 显示文摘Haufroid V Wallemacq P VanKerckhove V 2006Am J Transplant2006,6,11:1
18Evaluation of a new Sebia kit for analysis of hemoglobin fractions and variants on the Capillarys system显示文摘Louahabi A Philippe M Lali S Wallemacq P Maisin D 2006Clin Chem Lab Med2006,44,3:1
19Opportunities to optimize tacrolimus therapy in solid organ transplantation: report of the European consensus conference显示文摘Wallemacq P Armstrong VW Brunet M 2009Ther Drug Monit2009,31,2:1
20Pharmacokinetics of tacrolimus( FKS06 )in paediatric liver transplant recip ients 显示文摘WALLEMACQ P E FURLAN V MOLLER A 1998Eur J Drug Metab Pharmacokinet1998,23,3:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费